Jens‐Otto Andreas

Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies

Jan‐Peer Elshoff, Marina Braun, Jens‐Otto Andreas et al. · Clinical Therapeutics · 2012 · 108 citations

Pharmaceutical Science, Integrated Analysis, Medicine +11

Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)

I. Worret, W. Arp, H. P. Zahradnik et al. · Dermatology · 2001 · 88 citations · Full text

Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment

Willi Cawello, Hilmar Bökens, Brunhild Nickel et al. · Epilepsia · 2012 · 52 citations

Efficacy and Safety of the New Antiandrogenic Oral Contraceptive Belara®

H. P. Zahradnik, Jens‐Otto Andreas · Contraception · 1998 · 47 citations

Contraception, Contraceptive Use, Contraceptive Implants +13

Differential effects of human ether-a-go-go-related gene (HERG) blocking agents on QT duration variability in conscious dogs

Johannes Schneider, Renate Hauser, Jens‐Otto Andreas et al. · European Journal of Pharmacology · 2005 · 46 citations

Veterinary Behavioral Medicine, Qt Duration Variability, Medicine +9